Injection of 99mTc-NM-02

DRUG2 trials

Sponsors

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Breast CancerRadiotoxicity

Early Phase 1

HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02

CompletedNCT04040686

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineBreast Cancer

Start: 2019-07-29End: 2022-03-30Updated: 2023-04-14

HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody

CompletedNCT04674722

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineBreast Cancer, Radiotoxicity

Start: 2020-08-24End: 2024-10-30Updated: 2024-12-09

Related Papers

Detection of HER2 expression using <sup>99m</sup>Tc-NM-02 nanobody in patients with breast cancer: a non-randomized, non-blinded clinical trial.

2024-03-085 citations

<sup>99m</sup>Tc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types.

2022-12-0915 citations